Acute chest pain (ACP) is a common yet challenging presentation in clinical practice. It requires a systematic and comprehensive approach to prevent misdiagnosis, as it may indicate various life-threatening conditions such as acute coronary syndromes (ACS), pulmonary embolism, or aortic dissection.
The initial evaluation of ACP includes a thorough history and physical examination. The physician should focus on the onset, duration, character, and radiation of pain. The presence of associated symptoms such as dyspnea, diaphoresis, nausea, and syncope should also be considered. Risk factors for coronary artery disease should be assessed, and the physical examination should focus on vital signs, heart sounds, and pulmonary system.
Electrocardiogram (ECG) is the first-line diagnostic test in patients with ACP. Changes in ST-segment, T-wave, or the presence of a new left bundle branch block may suggest ACS. Cardiac biomarkers, such as troponins, should be measured at presentation and 3-6 hours after symptom onset. Chest radiography, coronary angiography, or computed tomography angiography may be required based on the initial evaluation.
Management of ACP is guided by the underlying cause. Patients with ACS should receive immediate reperfusion therapy. Those with non-cardiac chest pain may require symptomatic treatment and further evaluation for gastrointestinal or musculoskeletal causes. Risk stratification is essential to determine the need for hospital admission or outpatient management.
ACP is a complex clinical scenario requiring a comprehensive and systematic approach. It is crucial to promptly differentiate between cardiac and non-cardiac causes to initiate appropriate treatment. Keeping abreast of the latest guidelines and adopting a patient-centered approach can improve the outcomes and reduce the healthcare burden associated with ACP.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation